Skip to main content
Caplight Logo









9lione, Inc.

9lione, Inc.

Private
TokyoHealthcare & Life Scienceshttps://www.9lione.net/

Last Round

Series A

Sep 14, 2026

Est. Valuation

$11.4M

Total Funding Raised

$828,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

9lione, Inc. is a healthcare technology company that develops cloud-based medical supply and pharmaceutical inventory management systems for pharmacies and medical institutions.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Vertical SaaS, Supply Chain

Business Model

B2B

Customer Profile

Subscription SaaS, Marketplace Commission

AI Layer

Application

Keywords

pharmaceutical inventory managementhealthcare SaaSpharma supply chaindigital transformationDXmedical inventory softwarepharmacy management systemOCR technologydemand forecastingsecondary distribution marketplacemedical waste reductionmedtechhealthtechinventory automationB2B healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

9lione, Inc. Comparables

Compare 9lione, Inc. with similar companies based on industry and business-model similarity.

9lione, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pharma Cloud Inc.
86%
Kakehashi Inc.
82%
Kusurinomadoguchi, Inc.
79%

9lione, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 14, 2026
Series BDec 25, 2023
SeedJun 30, 2021
AcceleratorOct 1, 2018

9lione, Inc. Investors

Notable investors and investment history

9lione, Inc. investors
InvestorRounds
Open Network LabAccelerator
DG VenturesSeries A, Series B
Yokohama Capital Co., Ltd.Series B, Series A
Mitsui Sumitomo Insurance Capital Co., Ltd.Series A, Series B
Incubate FundSeries A, Seed
GA1号投資組合Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 14, 2026

    $780K round led by Yokohama Capital Co., Ltd.

  • Nov 7, 2025

    Monthly visitors grew 253% MoM, reaching 1.5K.

9lione, Inc. Filings

Explore SEC and related filing metadata, where available.

9lione, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 9lione, Inc.'s valuation, stock price, and market status.

Is 9lione, Inc. a public or private company?

9lione, Inc. is a private company.

What is the current stock price of 9lione, Inc.?

9lione, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is 9lione, Inc. worth (valuation)?

9lione, Inc.'s valuation is estimated at $11.4M based on funding round data.

Can I buy 9lione, Inc. stock?

9lione, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 9lione, Inc.'s last funding round?

9lione, Inc.'s most recent funding round was Series B on December 25, 2023.

Who are the main investors in 9lione, Inc.?

Key investors in 9lione, Inc. include Open Network Lab, Incubate Fund.

Will 9lione, Inc. IPO soon?

No public IPO plans have been announced for 9lione, Inc..

How can I track 9lione, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 9lione, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range1
Year Founded2018
Last FundingSep 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?